Xcout Intel
Rapid Novor
Rapid Novor is a contract research organization (CRO) specializing in antibody discovery, protein sequencing, and characterization services.
Subscribe to see Rapid Novor’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
Rapid Novor at a glance
Rapid Novor is a biotechnology company headquartered in Canada. Its most recent funding round, Series A, raised $5M in July 2020. Xcout tracks 3 named people at Rapid Novor, including Mingjie Xie (Co-founder and CEO).
Rapid Novor leadership
- Mingjie XieCo-founder and CEO
- Qixin LiuCo-founder and CTO
- Dr. Bin MaCo-Founder and Chief Scientist
Rapid Novor funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series A | $5M | 1 named |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Investors
Rapid Novor competitors
A few of Rapid Novor's closest competitors — see the full list of competitors and alternatives →
Biocytogen provides fully human antibody discovery services and preclinical contract research organization (CRO) services. The company offers genetically engineered animal models, cell lines, gene editing services, and in vivo and in vitro pharmacology studies to support biopharmaceutical research and drug development.
ProtaGene is a biotechnology research company and contract research organization (CRO) partner headquartered in Heilbronn, Germany, serving the biopharmaceutical, gene, and cell therapy industries.
Fusion Antibodies plc operates as a contract research organization (CRO), providing specialized services in the research, development, and manufacturing of recombinant proteins and antibodies. The company primarily focuses on solutions for oncology and infectious diseases, serving a global clientele across the United Kingdom, broader Europe, and North America. Its comprehensive suite of offerings encompasses monoclonal antibody discovery and advancement, antibody sequencing and engineering, and a distinct platform for antibody humanization and rational affinity maturation. Additionally, Fusion Antibodies provides recombinant protein expression, stable cell line development, and cGMP-compliant scale-up services. Clients span the pharmaceutical, biotechnology, and diagnostic sectors. Notably, the company maintains a collaborative partnership with Celonic AG. Established in 2000, Fusion Antibodies plc is headquartered in Belfast, United Kingdom.
Vironova (operating as QuTEM) is a GMP-certified provider of transmission electron microscopy (TEM) and cryogenic TEM analysis services for nanoparticles such as viral vectors, liposomes, and extracellular vesicles. The company serves pharmaceutical and gene therapy developers by providing quality control analysis, particle characterization, and traceable data to support product development and regulatory compliance.
Organoid Therapeutics, Inc. is a biotechnology contract research organization (CRO) that provides human brain tissue models, neuronal phenotyping, drug screening, and machine learning-based analytical services. The company serves pharmaceutical, biotech, and academic researchers by conducting pre-clinical research and translational studies to evaluate drug efficacy, neurotoxicity, and neurological disease models.
Novoprotein Scientific Inc. manufactures and supplies biological products including recombinant proteins, growth factors, cytokines, antibodies, and enzymes for scientific research, cell therapy, and pharmaceutical development. The company also provides comprehensive technical services such as protein expression and purification, antibody development, and RNA synthesis solutions to research institutes and pharmaceutical companies.
Get Rapid Novor's news by email
Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.
Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →
Share this card
Post the link and the card appears automatically — each network fetches the image itself.
More on Rapid Novor in Xcout Intel
- 3 named people with titles, LinkedIn and board committees
- 1 funding round with the investors in each, and who they co-invest with
- The full competitor set, tracking, exports and API access